Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Companies›Healthcare›Healthcare›Healthcare Services
NSE:SUVEN

SUVEN LIFE SCIENCES LTD

Healthcare › Healthcare Services·NIFTY MICROCAP 250NIFTY SMALLCAP 500NIFTY TOTAL MARKET
₹268.65
at close · 28 Oct 2026
▲ 6.45 (+2.46%)

Latest filings

  1. Special window to re-lodge rejected physical share transfer requests · Compliance
  2. Quarterly RTA certificate under SEBI Depositories Regulations filed · Compliance
  3. Trading Window Closed Ahead of Q2 FY26-27 Results · Compliance
All filings ↓
Ask Nexa about SUVEN LIFE SCIENCES LTD

Snapshot

What the business is, and whether it's a good one at a fair price.

A Healthcare Services company listed on NSE and BSE, reporting revenue of ₹9 Cr over the trailing twelve months.

Market Cap
₹7,092 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
-12.0%▼
Revenue 5y CAGR
PAT — · EBITDA —
Quality
-46.5%·
ROCE (5y median)
ROE -46.7% (5y median) · margin -3803.0%
Leverage
0.00·
Debt / Equity · low
Net cash ₹8.28 Cr
Revenue FY21→FY26
0.5×▼
Margin −3348.8 pts
₹13 Cr → ₹7 Cr
Moves on a normal day
1.97%·
Median daily move
Last 268 sessions · the yardstick for filing-day moves
Where it sits among 70 Healthcare Services peersBar = share of peers beaten · tick = industry median · latest reported figures
P/B#53/57
ROCE#66/69
ROE#55/57
Debt / Equity#1/56
EBITDA margin#56/57
Revenue growth#5/57
Profit growth#52/55

Scorecard

Measured from the filed financials, judged against its Healthcare Services peers · as of FY26 — not investment advice

Strengths
No borrowings on the balance sheet
lower than 80% of its 56 Healthcare Services peers
Negative working-capital cycle — the business is funded by its suppliers
Concerns
Revenue shrinking over 5 years (−12% a year)
Erratic profits — up in only 2 of the last 5 years
Negative returns on capital — −46.5% (5-year median)
#66 of 69 in Healthcare Services on the latest reported figures · up from −68.1% in FY21
Customers are taking longer to pay — 48 → 77 days of receivables
FY21 → FY26

Charts

How has the market priced it — with filings on the timeline?

SUVEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from SUVEN LIFE SCIENCES LTD's filed financials and exchange disclosures

What does SUVEN LIFE SCIENCES LTD do?

SUVEN LIFE SCIENCES LTD is a Healthcare Services company listed on NSE and BSE, trading under the symbol SUVEN.

Is SUVEN LIFE SCIENCES LTD profitable?

No. Over the trailing twelve months SUVEN LIFE SCIENCES LTD reported a net loss of ₹352 Cr on revenue of ₹8.81 Cr.

Does SUVEN LIFE SCIENCES LTD pay a dividend?

Not in the latest reported year — SUVEN LIFE SCIENCES LTD's dividend payout for FY26 was nil.

Is SUVEN LIFE SCIENCES LTD debt-free?

Yes. It reported no borrowings on its 31 Mar 2026 balance sheet, and ₹8.28 Cr of cash.

How much does the SUVEN LIFE SCIENCES LTD share price move in a day?

On a typical session SUVEN LIFE SCIENCES LTD moves 1.97% — that is the median absolute close-to-close move across its last 268 trading days. MarketPing measures each filing's price reaction against it.

Where can I track SUVEN LIFE SCIENCES LTD's announcements?

Every NSE and BSE filing by SUVEN LIFE SCIENCES LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.